| Univariate analysis | Multivariate analysis (MLM) | ||
---|---|---|---|---|
 | Odds ratio (95% CI) | P = | Odds ratio (95% CI) | P = |
No Hypertension | Â | Â | Â | Â |
Renal function not monitored | 1.21 (1.00-1.47) | 0.053 | 1.32 (1.07-1.64) | 0.011 |
No CKD | 1.00 (reference) | Â | 1.00 (reference) | - |
CKD all stages | 3.86 (2.15-6.94) | <0.001 | 1.34 (0.93-1.92) | 0.117 |
Hypertension | Â | Â | Â | Â |
Renal function not monitored | 2.07 (1.76-2.43) | <0.001 | 1.35 (1.13-1.63) | 0.001 |
No CKD | 1.16 (1.01-1.33) | 0.038 | 0.97 (0.84-1.11) | 0.629 |
CKD stages 1–2 | 1.66 (1.48-1.88) | <0.001 | 1.19 (1.03-1.36) | 0.015 |
CKD stages 3–5 | 2.39 (2.10-2.73) | <0.001 | 1.13 (0.98-1.31) | 0.090 |
CKD stages 3–5 with proteinuria | 4.38 (3.88-4.94) | <0.001 | 1.58 (1.36-1.83) | <0.001 |